Zobrazeno 1 - 10
of 96
pro vyhledávání: '"E, Telzak"'
Autor:
Edward E. Telzak, Judith Berger
Publikováno v:
Health Crisis Management in Acute Care Hospitals ISBN: 9783030958053
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45ec5b855ec10f6b6908e4d7bbfff75a
https://doi.org/10.1007/978-3-030-95806-0_4
https://doi.org/10.1007/978-3-030-95806-0_4
Autor:
Wafaa El-Sadr, Bruce R. Schackman, Jared A. Leff, Lisa Fitzpatrick, Edward E. Telzak, Megan Braunlin, Uriel R. Felsen, Ashley A. Eggman, Bernard M. Branson
Publikováno v:
Public Health Reports. 131:71-81
Objective. The HIV Prevention Trials Network (HPTN) 065 trial sought to expand HIV screening of emergency department (ED) patients in Bronx, New York, and Washington, D.C. This study assessed the testing costs associated with different expansion proc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9063303668d841051c930c181ce70ab4
https://doi.org/10.1177/00333549161310s109
https://doi.org/10.1177/00333549161310s109
Autor:
Barry S. Zingman, Tammey Naab, Edward E. Telzak, Laura McKinstry, Kate Buchacz, Elizabeth Greene, Wafaa El-Sadr, Lisa Fitzpatrick, Theresa Gamble, Pollyanna R Chavez, Brett Hanscom, Bernard M. Branson, Geetha Beauchamp
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 66(10)
BACKGROUND: Human immunodeficiency virus (HIV) testing is critical for both HIV treatment and prevention. Expanding testing in hospital settings can identify undiagnosed HIV infections. METHODS: To evaluate the feasibility of universally offering HIV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f8207b01af7e7c0833bda77ab895cce
https://pubmed.ncbi.nlm.nih.gov/29186421
https://pubmed.ncbi.nlm.nih.gov/29186421
Autor:
Gerald H. Mazurek, Fred R. Sattler, Beverly Metchock, Elizabeth Guy, Susan Swindells, Beatriz Grinsztejn, Marc H Weiner, Michel Fernandez, Diane V. Havlir, Debra Benator, Cynthia Firnhaber, Ian Sanne, Edward E. Telzak, Michelle A. Kendall, Anne F Luetkemeyer, Yun F. Wang, Roberto C. Arduino, David Alland, Xingye Wu, Pamela Johnson
Background The Xpert MTB/RIF (Xpert) assay is a rapid nucleic acid amplification test widely used in settings of high tuberculosis prevalence to detect tuberculosis as well asrpoBmutations associated with rifampin resistance. Data are needed on the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b26b2d2918940bc3d4d89c6313b25a79
https://europepmc.org/articles/PMC4826450/
https://europepmc.org/articles/PMC4826450/
Autor:
Andrew N. Phillips, Stefan Esser, Edward M. Gardner, Sharon B. Mannheimer, Alan R. Lifson, Edward E. Telzak, Jemma L O'Connor
Publikováno v:
The Journal of Infectious Diseases. 208:40-49
Background. We assessed factors associated with antiretroviral therapy (ART) adherence, including specific ART medications. Methods. The Strategies for Management of Antiretroviral Therapy study was an international antiretroviral therapy (ART) strat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80ef2152b4302f36dc3e96e0c62c64d1
https://doi.org/10.1093/infdis/jis731
https://doi.org/10.1093/infdis/jis731
Autor:
Cornelis A. Rietmeijer, Edward E. Telzak, Martin Fisher, William J. Burman, Robert Colebunders, Gerald Friedland, Jacqueline Neuhaus, John M. Douglas, Nicholas I. Paton, Birgit Grund
Publikováno v:
JAIDS
Not the final published version
OBJECTIVE: To compare the HIV transmission risk among patients randomized to episodic versus continuous antiretroviral therapy. DESIGN: This was a substudy of the Strategies of Management of Antiretroviral Therapy
OBJECTIVE: To compare the HIV transmission risk among patients randomized to episodic versus continuous antiretroviral therapy. DESIGN: This was a substudy of the Strategies of Management of Antiretroviral Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14d40907bd64eb10411023823660eb42
https://doi.org/10.1097/qai.0b013e318183a9ad
https://doi.org/10.1097/qai.0b013e318183a9ad
Autor:
Rodger D. MacArthur, John P. Matts, Sharon B. Mannheimer, Katherine Huppler Hullsiek, Edward E. Telzak, Gerald Friedland, Margaret A. Chesney, Edward M. Gardner, Albert W. Wu, Nicholas Wold
Publikováno v:
Clinical Infectious Diseases. 46:941-945
Symptoms and quality of life were assessed among human immunodeficiency virus (HIV)-infected individuals initiating their first course of antiretroviral therapy. Symptoms, which were mostly mild or moderate, were common in the first year and signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69ddeacee77ca6dab0af0e499bb3c93f
https://doi.org/10.1086/528859
https://doi.org/10.1086/528859
Autor:
Michael J. Kozal, Mary Van Der Berg-Wolf, Ying Xiang, Jonathan Uy, Edward E. Telzak, Grace Peng, John D. Baxter, Rodger D. MacArthur, Katherine Huppler Hullsiek, Richard M. Novak
Publikováno v:
HIV Clinical Trials. 8:357-370
Treatment-naïve participants were randomized to three antiretroviral strategies (all with nucleoside reverse transcriptase inhibitor [NRTI] background): protease inhibitor (PI), non-nucleoside reverse transcriptase inhibitor (NNRTI), or PI+NNRTI. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deafee71fdfced540a1562ae4c149434
https://doi.org/10.1310/hct0806-357
https://doi.org/10.1310/hct0806-357
Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence
Autor:
S. B. Mannheimer, J. Matts, E. Telzak, M. Chesney, C. Child, A. W. Wu, G. Friedland, null for The Terry Beirn Community Progr
Publikováno v:
AIDS Care. 17:10-22
This study assesses changes in quality of life (QoL) over time among HIV-infected individuals receiving antiretroviral therapy (ART) and evaluates how this relates to ARTadherence. Prospective, longitudinal data were examined from 1050 participants i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a3d0d5b2dd4217a60d97d1a20a9b826
https://doi.org/10.1080/09540120412331305098
https://doi.org/10.1080/09540120412331305098
Publikováno v:
Clinical Infectious Diseases. 29:321-327
Rates of invasive disease caused by penicillin-resistant pneumococci are rising. Previous reports have found no association between resistant pneumococci and increased mortality. To evaluate the impact of penicillin resistance and other variables on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4a9a363c693ae9d2f5cea66dcf0f0d5
https://doi.org/10.1086/520209
https://doi.org/10.1086/520209